Graceway Pharmaceuticals, LLC

25 articles about Graceway Pharmaceuticals, LLC

• 

  The Next Generation: Top 20 Life Science Startups to Watch in 2017

  1/9/2017

  BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.

• Medicis Announces Close of Graceway Pharmaceuticals, LLC Acquisition

  12/5/2011

• Medicis Snags Graceway Pharmaceuticals, LLC in $455 Million Bankruptcy Sale

  11/18/2011

• Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma Pharma S.A. for Undisclosed Amount

  9/28/2011

• FDA Approves Graceway Pharmaceuticals, LLC's Zyclara(R) (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses

  7/19/2011

• Graceway Pharmaceuticals, LLC Release: /R E P E A T -- Emotional Stigma Leaves Genital Warts Sufferers in the Dark/

  6/15/2011

• Graceway Pharmaceuticals, LLC Release: Data Demonstrate Zyclara(TM) (Imiquimod) Cream, 3.75% Greatly Improves Efficacy of Cryosurgery in Reducing Actinic Keratoses (AK)

  8/9/2010

• Graceway Pharmaceuticals, LLC Release: New Data Demonstrate Zyclara(TM) Imiquimod 3.75% Superior to Placebo for Treatment of External Genital Warts (EGW)

  7/9/2010

• Meda AB Acquires Exclusive Rights to New Treatment of Actinic Keratosis From Graceway Pharmaceuticals, LLC

  5/12/2010

• Perrigo Company and Graceway Pharmaceuticals, LLC Settle Litigation and Name Perrigo as the Authorized Generic Distributor for Aldara(R)

  4/13/2010

• FDA Approves Graceway Pharmaceuticals, LLC's Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses

  3/29/2010

• Graceway Pharmaceuticals, LLC Extends Partnership with NASCAR Camping World Truck Series Driver Aric Almirola; Adds Sprint Cup Series

  2/12/2010

• Health Canada Approves Graceway Pharmaceuticals, LLC Product for Precancerous Skin Condition

  1/5/2010

• Graceway Pharmaceuticals, LLC Acquires Worldwide Rights to GS 9191 from Gilead Sciences, Inc. (JOBS)

  11/6/2009

• I-many Government Pricing(TM) Goes Live at Graceway Pharmaceuticals, LLC

  7/15/2009

• Graceway Pharmaceuticals, LLC Buys Derma Molecule Rights from Pfizer Inc.

  7/6/2009

• Graceway Pharmaceuticals, LLC Reports Study in Journal of Pediatrics: ATOPICLAIR(R) is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children

  5/29/2008

• Graceway Pharmaceuticals, LLC Teams With Vivacare(SM) on Direct-to-Patient Communication for Dermatology Products

  5/12/2008

• Graceway Pharmaceuticals, LLC Reports Study in The New England Journal of Medicine: ALDARA(R) (imiquimod) Cream, 5% Demonstrated a Reduction in Lesion Size in Patients with Vulvar Intraepithelial Neoplasia (VIN)

  4/21/2008

• Graceway Pharmaceuticals, LLC Reports Study in British Journal of Dermatology: Patients Treated with ALDARA Experienced Higher Levels of Histological and Sustained Clearance for Actinic Keratosis (AK) than Patients in two Other Common AK Treatments

  4/16/2008